ClinicalTrials.gg
CompletedNCT07149012Updated Aug 29, 2025

Artificial Intelligence for Surgical Care in War-Torn Sudan: Feasibility, Barriers, and Ethical Perspectives

An observational study in Surgical Procedures, Operative, Artificial Intelligence (AI) and War Injury, sponsored by Sudan Medical Specialization Board. Completed at 1 site in Sudan. Per ClinicalTrials.gov, last updated 2025-08-29.

Sponsored by Sudan Medical Specialization Board · Observational

Study type
Observational
Model
Other
Time perspective
Other
Enrollment
185
Sex
All
01

Study summary

This study is designed to examine how artificial intelligence (AI) could be applied to support surgical care in Sudan during the ongoing armed conflict. The conflict has disrupted hospital operations, displaced surgical teams, and limited access to specialists and modern technology. The investigators are conducting a survey of Sudanese surgeons working in public, private, military, and conflict-zone hospitals to assess awareness of AI, interest in its application, and perceived challenges. In addition, in-depth interviews with senior surgeons and residents are being performed to further explore perspectives on AI in surgical care.

This study represents one of the first attempts to investigate the role of AI in surgery within an active conflict setting in Africa. Findings from this research are expected to inform the design of AI tools that are tailored for fragile health systems, including offline and low-bandwidth environments.

02

Conditions studied

  • Surgical Procedures, Operative
  • Artificial Intelligence (AI)
  • War Injury
  • Wounds and Injuries
  • Disasters
  • Health Services Accessibility
  • Developing Countries

Browse trials for

Keywords

  • Artificial Intelligence
  • Surgeon Training
  • Technology Adoption in Surgery
  • Humanitarian Health
03

In context

Wounds and Injuries

2,217 studies on the registry are indexed under Wounds and Injuries; 441 are open to participants now.

This study's enrollment of 185 is close to the median of 169 across 690 observational studies indexed under Wounds and Injuries.

Browse Wounds and Injuries studies →

Lead sponsor

Sudan Medical Specialization Board is the lead sponsor of 5 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

General surgery residents and consultants practicing in Sudan during the ongoing armed conflict, representing public, private, military, NGO, and conflict-zone hospitals across multiple regions. Participants include surgeons at various training levels, from early-year residents to senior consultants.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Sudanese general surgery residents or consultants.
  • Currently working in public, private, military, NGO, or conflict-zone hospitals within Sudan.
  • Able to provide .

Exclusion criteria

Exclusion Criteria:

  • Surgeons working outside Sudan.
  • Non-surgical medical specialties.
  • Inability or unwillingness to complete the survey or participate in interviews.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Other
Time perspective
Other
Enrollment
185 participants (actual)
Patient registry
No

Interventions

  • OtherArtificial Intelligence Awareness and Feasibility Assessment

    A sequential explanatory mixed-methods assessment of surgeons' awareness, readiness, and perceived barriers to adopting artificial intelligence in surgical care during the ongoing Sudan conflict. The intervention consisted of: A validated, structured online questionnaire adapted from established AI awareness tools, assessing familiarity, perceived benefits, barriers, and ethical concerns. Semi-structured interviews with senior surgical residents and consultants to explore contextual and ethical perspectives in greater depth. The study did not implement AI tools in practice but focused on measuring feasibility and identifying requirements for future AI deployment in conflict-affected surgical systems.

    Also known as: AI Readiness Survey, AI in Surgical Care Study Sudan, AI Training and Barriers Assessment

06

What researchers measure

Primary outcomes

  1. Awareness of Artificial Intelligence in Surgical Care Among Sudanese Surgeons

    Measured using a structured questionnaire including domains of familiarity with AI concepts, perceived benefits, and potential applications in perioperative care. Responses are recorded on a 5-point Likert scale ranging from 1 (not at all familiar/beneficial/applicable) to 5 (very familiar/beneficial/applicable). Higher scores indicate greater awareness and more positive perceptions.

    Time frame: At survey completion (October 2024 - June 2025)

07

Study locations

1 site
  • Sudan Medical Specialization Board
    Wad Medani, Al Jazirah 14552, Sudan
08

References and documents

Publications

  • Alsaedi AR, Alneami N, Almajnoni F, Alamri O, Aljohni K, Alrwaily MK, Eid M, Budayr A, Alrehaili MA, Alghamdi MM, Almutairi ED, Eid MH. Perceived Worries in the Adoption of Artificial Intelligence Among Healthcare Professionals in Saudi Arabia: A Cross-Sectional Survey Study. Nurs Rep. 2024 Nov 28;14(4):3706-3721. doi: 10.3390/nursrep14040271. PubMed 39728632 ↗
  • Fleming CA, Ali O, Clements JM, Hirniak J, King M, Mohan HM, Nally DM, Burke J; Association of Surgeons in Training (ASIT). Surgical trainee experience and opinion of robotic surgery in surgical training and vision for the future: a snapshot study of pan-specialty surgical trainees. J Robot Surg. 2022 Oct;16(5):1073-1082. doi: 10.1007/s11701-021-01344-y. Epub 2021 Nov 26. PubMed 34826106 ↗
  • De Simone B, Abu-Zidan FM, Gumbs AA, Chouillard E, Di Saverio S, Sartelli M, Coccolini F, Ansaloni L, Collins T, Kluger Y, Moore EE, Litvin A, Leppaniemi A, Mascagni P, Milone L, Piccoli M, Abu-Hilal M, Sugrue M, Biffl WL, Catena F. Knowledge, attitude, and practice of artificial intelligence in emergency and trauma surgery, the ARIES project: an international web-based survey. World J Emerg Surg. 2022 Feb 10;17(1):10. doi: 10.1186/s13017-022-00413-3. PubMed 35144645 ↗

Individual participant data

Plan to share: No — Individual participant data (IPD) will not be shared because the dataset contains sensitive information collected from healthcare professionals working in conflict-affected regions. Sharing could risk identification of participants despite anonymization, given the small and specialized population.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Oct 2024 to primary completion in Jun 2025, 8 months.

Of 265 non-industry observational studies under Wounds and Injuries, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 60. This study's 8 months is below that.

Counting every sponsor, half of 312 studies reached it within 28 months; a quarter within 12 and three quarters within 60.

Wounds and Injuries covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2025
First posted
Aug 29, 2025
StartActual
Oct 1, 2024
Primary completionActual
Jun 1, 2025
CompletionActual
Jun 1, 2025
Last update
Aug 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07149012
Lead sponsor
Sudan Medical Specialization Board
Responsible party
Alsadig Suliman (Principal Investigator, Sudan Medical Specialization Board) — Principal investigator
First posted
Aug 29, 2025
Start date
Oct 1, 2024
Primary completion
Jun 1, 2025
Completion
Jun 1, 2025
Last update
Aug 29, 2025

Study contacts

Alsadig Suliman, MBBS, Msc
principal investigator · Sudan Medical Specialization Board

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion